HCN Channel

HCN channel blockers act on pacemaker ion channels that open when the cell membrane hyperpolarizes. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels carry the funny current in the sinoatrial node and the related Ih current in neurons. In 1991 cyclic adenosine monophosphate (cAMP) was shown to activate cardiac pacemaker channels directly from the inside of the membrane. The genes were cloned in 1998, and mammals have four isoforms, HCN1 to HCN4. Blockers are used to study heart rate, neuronal excitability, dendritic integration and pain. Ivabradine HCl, zatebradine and cilobradine hydrochloride belong to the bradine group of pore blockers. ZD7288 is widely used in brain slices, and RO-275 and HCN2-IN-3 are aimed at HCN1 and HCN2.

17 Items

  • Zatebradine
    Cat. No.
    A21364

    Zatebradine

    Synonyms: UL-FS-49 free base; UL-FS-49CL free base

    Zatebradine (UL-FS-49 (free base); UL-FS-49CL (free base)) is a potent inhibitor of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels with an IC50 value of 1.96 µM.

    2 mg
    $40.00
    5 mg
    $70.00
    All 5 sizes
  • Zatebradine hydrochloride
    Cat. No.
    A21669

    Zatebradine hydrochloride

    Synonyms: UL-FS-49; UL-FS-49CL

    Zatebradine (UL-FS-49 (free base)) is a potent inhibitor of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels with an IC50 values 1.96 µM.

    5 mg
    $40.00
    10 mg
    $65.00
    All 6 sizes
  • HCN-IN-1
    Cat. No.
    A65657

    HCN-IN-1

    HCN-IN-1 is a TLR4 inhibitor and modulator of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, specifically targeting HCN2 and HCN4. It effectively inhibits TLR4-mediated signaling, evidenced by reduced alkaline phosphatase activity. HCN-IN-1 modulates HCN2 currents by shifting the voltage-dependent activation to hyperpolarized potentials and slowing activation kinetics, while also blocking currents through HCN4 channels. This compound demonstrates significant analgesic, anti-inflammatory, and anti-anginal properties, making it valuable for research into inflammatory pain, neuropathic pain, heart failure, and related inflammatory conditions.

    Out of stock

    All 3 sizes
  • RO-275
    Cat. No.
    A67037

    RO-275

    RO-275 is a potent and selective HCN1 inhibitor, demonstrating IC50 values of 0.046 µM for HCN1, while showing significantly lower activity against HCN2 (14.3 µM), HCN3 (4.6 µM), and HCN4 (13.9 µM). This compound has been shown to effectively rescue impaired working memory, highlighting its potential utility in researching cognitive dysfunction associated with various brain disorders. RO-275 serves as a valuable tool for investigations into HCN1-related pathways and their implications in neurobiology.

    1 mg
    $130.00
    5 mg
    $340.00
    All 5 sizes
  • HCN2-IN-3
    Cat. No.
    A67038

    HCN2-IN-3

    HCN2-IN-3 is an orally active inhibitor of HCN2 ion channels. It effectively reduces the activity of HCN2, making it valuable for research into pain mechanisms, tinnitus, and various central nervous system disorders. Additionally, HCN2-IN-3 has potential applications in studies focusing on mental illnesses and mood-related conditions.

    Out of stock

    All 3 sizes
  • HCN2-IN-6
    Cat. No.
    A67039

    HCN2-IN-6

    HCN2-IN-6 is a selective inhibitor of the HCN2 ion channel, demonstrating an IC50 value of 7 nM. It exhibits minimal inhibition of HCN4, making it a valuable tool for studying HCN2-specific pathways. This reagent is suitable for research into inflammatory diseases and neurological disorders, facilitating the exploration of potential therapeutic strategies targeting these conditions.

    Out of stock

    All 3 sizes
  • pan-HCN-IN-1
    Cat. No.
    A67041

    pan-HCN-IN-1

    pan-HCN-IN-1 is a potent inhibitor of the hyperpolarization-activated and cyclic-nucleotide-gated 1 (HCN1) ion channel, exhibiting an IC50 value of 58 nM. This compound effectively attenuates the voltage sag response and enhances excitatory postsynaptic potential (EPSP) summation in ex vivo rat brain slices. It serves as a valuable tool for investigating the role of HCN1 channels in neuronal excitability and synaptic integration in various research applications.

    5 mg
    $355.00
    10 mg
    $590.00
    All 5 sizes
  • MS7710
    Cat. No.
    A67043

    MS7710

    MS7710 is a potent inhibitor of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. It effectively reduces HCN channel-mediated Ih current, leading to decreased firing frequency and burst activity in dopaminergic neurons within the ventral tegmental area. Research has demonstrated that MS7710 ameliorates deficits in social interaction and cognitive flexibility related to reward processing in mice subjected to chronic social defeat stress. This compound is valuable for studies focusing on major depressive disorder and its underlying mechanisms.

    5 mg
    $185.00
    10 mg
    $300.00
    All 5 sizes
  • HCN2-IN-4
    Cat. No.
    A67050

    HCN2-IN-4

    HCN2-IN-4 is an orally active inhibitor of the HCN2 ion channel, which plays a crucial role in neuronal excitability and rhythmic activity. This compound effectively inhibits HCN2 channel activity, making it a valuable tool for investigating its involvement in pain mechanisms, tinnitus, and various central nervous system disorders. Researchers may utilize HCN2-IN-4 to explore therapeutic strategies targeting these conditions.

    Out of stock

    All 3 sizes
  • HCN2-IN-2
    Cat. No.
    A67051

    HCN2-IN-2

    HCN2-IN-2 is a selective inhibitor of the HCN2 ion channel, characterized by an IC50 of 145 nM. This azaindazole derivative effectively blocks HCN2 channel activity, preventing abnormal firing in peripheral nociceptive neurons. HCN2-IN-2 is suited for research applications focused on pain modulation and the underlying mechanisms of nociceptive signaling.

    Out of stock

    All 3 sizes
  • HCN2-IN-1
    Cat. No.
    A67053

    HCN2-IN-1

    HCN2-IN-1 is a potent HCN2 inhibitor with an IC50 of 98 nM. This compound selectively targets hyperpolarization-activated cyclic nucleotide-gated channels, making it a valuable tool for investigating central nervous system (CNS) and psychiatric disorders. HCN2-IN-1 can facilitate research into the mechanisms underlying neuronal excitability and potential therapeutic strategies for related conditions.

    Out of stock

    All 3 sizes
  • HCN2 modulator-6
    Cat. No.
    A67054

    HCN2 modulator-6

    HCN2 modulator-6 is a potent inhibitor of the HCN2 ion channel, exhibiting an IC50 of 7 nM. This compound effectively suppresses HCN2 channel activity, making it a valuable tool for investigating mechanisms underlying pain, including inflammatory and neuropathic pain. Additionally, HCN2 modulator-6 is applicable in research focused on tinnitus, central nervous system disorders, psychiatric conditions, and mood disorders.

    Out of stock

    All 3 sizes
  • HCN2-IN-5
    Cat. No.
    A67056

    HCN2-IN-5

    HCN2-IN-5 is a potent HCN2 ion channel inhibitor with an IC50 of 9 nM, exhibiting minimal inhibitory activity on HCN4. This compound is valuable in the study of inflammatory diseases and neurological disorders, providing insights into the modulation of ion channel activity. Its specificity and potency make it a useful tool for elucidating the role of HCN2 in various physiological and pathological processes.

    Out of stock

    All 3 sizes
  • dMeThPmR
    Cat. No.
    A67773

    dMeThPmR

    dMeThPmR is a selective inhibitor of the human nucleoside transporter 1 (hCNT1), exhibiting a potent inhibitory constant (Ki) in the range of 0.3-0.98 μM. While dMeThPmR shows minimal inhibition of hCNT2 (IC50 = 133 μM) and hCNT3 (Ki = 32.7 μM), it effectively protects cells from the cytotoxic effects of nucleoside drugs. This compound is valuable for research on cancer and related therapies, providing insights into nucleoside transport mechanisms and drug interactions.

    Out of stock

    All 3 sizes
  • MeThPmR
    Cat. No.
    A67774

    MeThPmR

    MeThPmR is a potent and selective inhibitor of the human nucleoside transporter 1 (hCNT1) with a Ki ranging from 0.16 to 0.69 μM. It exhibits minimal inhibitory activity on hCNT2 (IC50 = 360 μM) and hCNT3 (Ki = 4.7 μM). MeThPmR has been demonstrated to provide protection against the cytotoxic effects of nucleoside drugs, making it a valuable tool for cancer research applications.

    Out of stock

    All 3 sizes
  • HCN2 modulator-8
    Cat. No.
    A68104

    HCN2 modulator-8

    HCN2 modulator-8 is a selective inhibitor of the HCN2 channel, classified as a pyrazolopyridine derivative. It exhibits significant activity in modulating hyperalgesic and sensory signaling pathways, making it valuable for research into pain management, tinnitus, and various central nervous system disorders, including psychiatric and mood disorders.

    Out of stock

    All 3 sizes
  • HCN2 modulator-5
    Cat. No.
    A68244

    HCN2 modulator-5

    HCN2 modulator-5 is a selective inhibitor of the HCN2 ion channel. This compound effectively reduces HCN2 channel activity, making it a valuable tool for investigating mechanisms underlying pain, inflammatory conditions, neuropathic pain, and tinnitus. Additionally, HCN2 modulator-5 can contribute to research focused on central nervous system and psychiatric disorders, including mood disorders.

    Out of stock

    All 3 sizes

17 Items

Added to your cart

View Cart Checkout

    Loading...